2016
DOI: 10.1590/0102-6720201600040006
|View full text |Cite
|
Sign up to set email alerts
|

Pediatric Liver Transplantation With Ex-Situ Liver Transection and the Application of the Human Fibrinogen and Thrombin Sponge in the Wound Area

Abstract: Background: Surgical strategy to increase the number of liver transplants in the pediatric population is the ex-situ liver transection (reduction or split). However, it is associated with complications such as hemorrhage and leaks. The human fibrinogen and thrombin sponge is useful for improving hemostasis in liver surgery. Aim: Compare pediatric liver transplants with ex-situ liver transection (reduction or split) with or without the human fibrinogen and thrombin sponge. Methods: Was performed a prospective a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…These devices are the main goals of surgeons in trials to improve results. To obtain effective hemostasis from traumatic or surgical lesions of parenchymal viscera, especially the liver, has always been a challenge 11 , 12 , 15 . The possibility of use of different substances leaded to the production of collagen and lower inflammatory reaction, when compared with conventional sutures 2 , 4 , 5 , 10 …”
Section: Introductionmentioning
confidence: 99%
“…These devices are the main goals of surgeons in trials to improve results. To obtain effective hemostasis from traumatic or surgical lesions of parenchymal viscera, especially the liver, has always been a challenge 11 , 12 , 15 . The possibility of use of different substances leaded to the production of collagen and lower inflammatory reaction, when compared with conventional sutures 2 , 4 , 5 , 10 …”
Section: Introductionmentioning
confidence: 99%
“…The first liver transplantation in humans was done in the 60s by Thomas Starzl. Since that time to the current days several landmarks have been conquered improving surgical technique, ameliorating grafts preservation during transportation, controlling cellular rejection, and preventing infections on post-transplantation period 19 , 20 , 22 .…”
Section: Introductionmentioning
confidence: 99%